tiprankstipranks
Chemours ‘tracking slightly below’ low end of FY22 adjusted EBITDA, FCF guidance
The Fly

Chemours ‘tracking slightly below’ low end of FY22 adjusted EBITDA, FCF guidance

Chemours said it is currently tracking slightly below the low end of its FY22 adjusted EBITDA guidance of $1.4B-$1.45B and free cash flow guidance of greater than $575M. In investor presentation slides, Chemours said TiO2 market demand has weakened in Q4 and it is taking strategic cost actions in order to better position the business for 2023 and beyond. Chemours shares are down about 6% in pre-market trading.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on CC:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles